These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21524581)

  • 1. Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.
    Prat M; Buil MA; Fernández MD; Castro J; Monleón JM; Tort L; Casals G; Ferrer M; Huerta JM; Espinosa S; López M; Segarra V; Gavaldà A; Miralpeix M; Ramos I; Vilella D; González M; Córdoba M; Cárdenas A; Antón F; Beleta J; Ryder H
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3457-61. PubMed ID: 21524581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).
    Prat M; Fernández D; Buil MA; Crespo MI; Casals G; Ferrer M; Tort L; Castro J; Monleón JM; Gavaldà A; Miralpeix M; Ramos I; Doménech T; Vilella D; Antón F; Huerta JM; Espinosa S; López M; Sentellas S; González M; Albertí J; Segarra V; Cárdenas A; Beleta J; Ryder H
    J Med Chem; 2009 Aug; 52(16):5076-92. PubMed ID: 19653626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.
    Prat M; Buil MA; Fernández MD; Tort L; Monleón JM; Casals G; Ferrer M; Castro J; Gavaldà A; Miralpeix M; Ramos I; Vilella D; Huerta JM; Espinosa S; Hernández B; Segarra V; Córdoba M
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1736-1741. PubMed ID: 25800115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel quinuclidinyl heteroarylcarbamate derivatives as muscarinic receptor antagonists.
    Nagashima S; Matsushima Y; Hamaguchi H; Nagata H; Kontani T; Moritomo A; Koshika T; Takeuchi M
    Bioorg Med Chem; 2014 Jul; 22(13):3478-87. PubMed ID: 24837158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.
    Starck JP; Talaga P; Quéré L; Collart P; Christophe B; Lo Brutto P; Jadot S; Chimmanamada D; Zanda M; Wagner A; Mioskowski C; Massingham R; Guyaux M
    Bioorg Med Chem Lett; 2006 Jan; 16(2):373-7. PubMed ID: 16275087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD.
    Starck JP; Provins L; Christophe B; Gillard M; Jadot S; Lo Brutto P; Quéré L; Talaga P; Guyaux M
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2675-8. PubMed ID: 18359633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.
    Lainé DI; Xie H; Buffet N; Foley JJ; Buckley P; Webb EF; Widdowson KL; Palovich MR; Belmonte KE
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6066-9. PubMed ID: 17911022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine urea muscarinic acetylcholine receptor antagonists: achiral quaternary ammonium groups.
    Jin Q; Davis RS; Bullion AM; Jin J; Wang Y; Widdowson KL; Palovich MR; Foley JJ; Schmidt DB; Buckley PT; Webb EF; Salmon M; Belmonte KE; Sarau HM; Busch-Petersen J
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7087-91. PubMed ID: 23099092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-(2-Benzofuranyl)quinuclidin-2-ene derivatives: novel muscarinic antagonists.
    Nordvall G; Sundquist S; Johansson G; Glas G; Nilvebrant L; Hacksell U
    J Med Chem; 1996 Aug; 39(17):3269-77. PubMed ID: 8765510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.
    Naito R; Yonetoku Y; Okamoto Y; Toyoshima A; Ikeda K; Takeuchi M
    J Med Chem; 2005 Oct; 48(21):6597-606. PubMed ID: 16220976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Heteroarylquinuclidin-2-ene derivatives as muscarinic antagonists: synthesis, structure-activity relationships and molecular modelling.
    Nordvall G; Nilsson BM; Sundquist S; Johansson G; Glas G; Nilvebrant L; Hacksell U
    Prog Brain Res; 1996; 109():141-5. PubMed ID: 9009700
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimuscarinic 3-(2-furanyl)quinuclidin-2-ene derivatives: synthesis and structure-activity relationships.
    Johansson G; Sundquist S; Nordvall G; Nilsson BM; Brisander M; Nilvebrant L; Hacksell U
    J Med Chem; 1997 Nov; 40(23):3804-19. PubMed ID: 9371246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel and long acting muscarinic acetylcholine receptor antagonists.
    Jin J; Wang Y; Shi D; Wang F; Davis RS; Jin Q; Fu W; Foley JJ; Webb EF; Dehaas CJ; Berlanga M; Burman M; Sarau HM; Morrow DM; Rao P; Kallal LA; Moore ML; Rivero RA; Palovich M; Salmon M; Belmonte KE; Busch-Petersen J
    J Med Chem; 2008 Aug; 51(16):4866-9. PubMed ID: 18680280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery of AZD9164, a novel muscarinic M3 antagonist.
    Mete A; Bowers K; Chevalier E; Donald DK; Edwards H; Escott KJ; Ford R; Grime K; Millichip I; Teobald B; Russell V
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7440-6. PubMed ID: 22047691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.
    Lainé DI; McCleland B; Thomas S; Neipp C; Underwood B; Dufour J; Widdowson KL; Palovich MR; Blaney FE; Foley JJ; Webb EF; Luttmann MA; Burman M; Belmonte K; Salmon M
    J Med Chem; 2009 Apr; 52(8):2493-505. PubMed ID: 19317446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).
    Peretto I; Fossati C; Giardina GA; Giardini A; Guala M; La Porta E; Petrillo P; Radaelli S; Radice L; Raveglia LF; Santoro E; Scudellaro R; Scarpitta F; Cerri A; Menegon S; Dondio GM; Rizzi A; Armani E; Amari G; Civelli M; Villetti G; Patacchini R; Bergamaschi M; Bassani F; Delcanale M; Imbimbo BP
    J Med Chem; 2007 Apr; 50(7):1693-7. PubMed ID: 17352463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.
    Dallanoce C; De Amici M; Barocelli E; Bertoni S; Roth BL; Ernsberger P; De Micheli C
    Bioorg Med Chem; 2007 Dec; 15(24):7626-37. PubMed ID: 17889543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and optimization of novel and selective muscarinic M(3) receptor antagonists.
    Kumar N; Kaur K; Aeron S; Dharmarajan S; Silamkoti AD; Mehta A; Gupta S; Chugh A; Gupta JB; Salman M; Palle VP; Cliffe IA
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5256-60. PubMed ID: 17629699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.
    Varoli L; Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Bedini A; Fazio N; Spampinato S
    Bioorg Med Chem Lett; 2008 May; 18(9):2972-6. PubMed ID: 18395442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and structure-activity relationship of a novel spirocarbamate series of NPY Y5 antagonists.
    Leslie CP; Bentley J; Biagetti M; Contini S; Di Fabio R; Donati D; Genski T; Guery S; Mazzali A; Merlo G; Pizzi DA; Sacco F; Seri C; Tessari M; Zonzini L; Caberlotto L
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6103-7. PubMed ID: 20813523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.